Encapsulated Glioma — Trials

Encapsulated Glioma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 116
Recruiting: 55
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03763422	Trial in Low Grade Glioma Patients: Wait or Treat(IWOT)	terminated	Phase 3	19	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	10	Feb 1, 2022	clinicaltrials
NCT00897377	Treatment Strategy for Low-grade Gliomas	terminated	Phase 3	500	Sun Yat-sen UniversityOTHER	1	Aug 5, 2014	clinicaltrials